(高级)地区经理 at Eli Lilly and Company

Kunming, China

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • 全日制本科学历,临床、药学等相关专业优先。
  • 有外资药企销售经验5年以上,团队管理经验2年以上。
  • 影响力,积极主动,应变能力,创新正值、诚实、富有激情,有良好的抗压性与奉献精神,重视团队协作。
  • 有良好的组织协调能力,沟通表达能力及谈判能力,目标导向。
  • Internal Candidates
  • 专员以上或者非销售职位专员以上行业外企5年以上工作经验。
  • 至少在 Lilly 有 2 年工作经验。
  • 连续的优异绩效在过去一年,无 “书面警告” 或以上级别的合规警告。

Responsibilities

  • 负责管理所辖区域和产品组的各项业务,制定地区目标、销售策略和发展方向。
  • 负责区域的人员招聘、团队的发展、员工绩效管理和教导。
  • 严格遵从国家以及公司的政策,确保团队的合规性、学术性、专业性。
  • 完成公司以及大区下达的销售及其他工作目标。
  • 确保专业拜访和学术研讨活动的全面实施和及时反馈。
  • 与重点学术带头人和专家保持良好沟通,以确保和支持市场活动的学术专业性。
  • 及时反馈客户疾病诊疗信息、品牌使用信息及市场信息的变化。
  • 组织和协调跨部门的合作,完成共同目标。

Skills

Sales Management
Team Leadership
Performance Management
Compliance
Strategic Planning
Recruitment
Negotiation
Communication
Customer Relationship Management
Market Analysis
Cross-functional Collaboration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI